12/23
10:05 am
oprx
OptimizeRx Stock: A Buy-The-Dip Opportunity For This Above-Average Growth Story [Seeking Alpha]
Low
Report
OptimizeRx Stock: A Buy-The-Dip Opportunity For This Above-Average Growth Story [Seeking Alpha]
12/17
07:26 am
oprx
OptimizeRx (NASDAQ:OPRX) was downgraded by analysts at Zacks Research from a "strong-buy" rating to a "hold" rating.
Medium
Report
OptimizeRx (NASDAQ:OPRX) was downgraded by analysts at Zacks Research from a "strong-buy" rating to a "hold" rating.
12/17
05:38 am
oprx
OptimizeRx Continues Expansion of the Company's Point-Of-Care Network [Yahoo! Finance]
Medium
Report
OptimizeRx Continues Expansion of the Company's Point-Of-Care Network [Yahoo! Finance]
12/17
04:30 am
oprx
OptimizeRx Continues Expansion of the Company’s Point-Of-Care Network
Medium
Report
OptimizeRx Continues Expansion of the Company’s Point-Of-Care Network
12/14
01:26 am
oprx
Low
Report
12/10
08:36 am
oprx
Looking at the Narrative for OptimizeRx After Guidance Boost and Recurring Revenue Shift [Yahoo! Finance]
Low
Report
Looking at the Narrative for OptimizeRx After Guidance Boost and Recurring Revenue Shift [Yahoo! Finance]
12/10
04:10 am
oprx
OptimizeRx (NASDAQ:OPRX) had its "sell (d+)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
OptimizeRx (NASDAQ:OPRX) had its "sell (d+)" rating reaffirmed by analysts at
Weiss Ratings.
11/26
12:30 am
oprx
How Recent Developments Are Shaping the OptimizeRx Investment Story [Yahoo! Finance]
Low
Report
How Recent Developments Are Shaping the OptimizeRx Investment Story [Yahoo! Finance]
11/18
01:18 pm
oprx
OptimizeRx (NASDAQ:OPRX) had its "sell (d+)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
OptimizeRx (NASDAQ:OPRX) had its "sell (d+)" rating reaffirmed by analysts at
Weiss Ratings.
11/18
07:21 am
oprx
OptimizeRx (NASDAQ:OPRX) was upgraded by analysts at Zacks Research from a "hold" rating to a "strong-buy" rating.
Medium
Report
OptimizeRx (NASDAQ:OPRX) was upgraded by analysts at Zacks Research from a "hold" rating to a "strong-buy" rating.
11/17
08:06 am
oprx
OptimizeRx (NASDAQ:OPRX) had its price target lowered by analysts at Stephens from $20.00 to $17.00. They now have an "equal weight" rating on the stock.
Medium
Report
OptimizeRx (NASDAQ:OPRX) had its price target lowered by analysts at Stephens from $20.00 to $17.00. They now have an "equal weight" rating on the stock.
11/10
12:38 am
oprx
OptimizeRx (OPRX) Q3 2025 Earnings Call Transcript [Yahoo! Finance]
Medium
Report
OptimizeRx (OPRX) Q3 2025 Earnings Call Transcript [Yahoo! Finance]
11/8
07:05 pm
oprx
How Recent Upgrades Are Changing the OptimizeRx Story According to Analysts [Yahoo! Finance]
Medium
Report
How Recent Upgrades Are Changing the OptimizeRx Story According to Analysts [Yahoo! Finance]
11/8
01:17 pm
oprx
Medium
Report
11/7
09:06 am
oprx
OptimizeRx (NASDAQ:OPRX) had its price target raised by analysts at Citizens Jmp from $23.00 to $24.00. They now have a "market outperform" rating on the stock.
High
Report
OptimizeRx (NASDAQ:OPRX) had its price target raised by analysts at Citizens Jmp from $23.00 to $24.00. They now have a "market outperform" rating on the stock.
11/7
05:59 am
oprx
OptimizeRx Corporation (OPRX) Q3 2025 Earnings Call Transcript [Seeking Alpha]
High
Report
OptimizeRx Corporation (OPRX) Q3 2025 Earnings Call Transcript [Seeking Alpha]
11/6
04:01 pm
oprx
OptimizeRx Reports Third Quarter 2025 Financial Results and Increases Fiscal Year 2025 Guidance
High
Report
OptimizeRx Reports Third Quarter 2025 Financial Results and Increases Fiscal Year 2025 Guidance
10/20
08:00 am
oprx
OptimizeRx Sets Third Quarter 2025 Conference Call for November 6, 2025, at 4:30 p.m. ET
Low
Report
OptimizeRx Sets Third Quarter 2025 Conference Call for November 6, 2025, at 4:30 p.m. ET
10/10
08:53 am
oprx
OptimizeRx (NASDAQ:OPRX) had its price target raised by analysts at JMP Securities from $20.00 to $23.00. They now have a "market outperform" rating on the stock.
Low
Report
OptimizeRx (NASDAQ:OPRX) had its price target raised by analysts at JMP Securities from $20.00 to $23.00. They now have a "market outperform" rating on the stock.
10/10
07:20 am
oprx
OptimizeRx (NASDAQ:OPRX) had its "outperform" rating reaffirmed by analysts at Citigroup Inc..
Low
Report
OptimizeRx (NASDAQ:OPRX) had its "outperform" rating reaffirmed by analysts at Citigroup Inc..
10/10
07:19 am
oprx
OptimizeRx (NASDAQ:OPRX) was given a new $23.00 price target on by analysts at UBS Group AG.
Low
Report
OptimizeRx (NASDAQ:OPRX) was given a new $23.00 price target on by analysts at UBS Group AG.
10/9
07:15 am
oprx
OptimizeRx (NASDAQ:OPRX) was downgraded by analysts at Zacks Research from a "strong-buy" rating to a "hold" rating.
Low
Report
OptimizeRx (NASDAQ:OPRX) was downgraded by analysts at Zacks Research from a "strong-buy" rating to a "hold" rating.
10/7
10:06 pm
oprx
OptimizeRx: How The Stock Is Changing Pharma Marketing [Seeking Alpha]
Medium
Report
OptimizeRx: How The Stock Is Changing Pharma Marketing [Seeking Alpha]
9/30
12:38 pm
oprx
OptimizeRx Bets on AI and Workflow Integration - Will This Pay Off? [Yahoo! Finance]
Low
Report
OptimizeRx Bets on AI and Workflow Integration - Will This Pay Off? [Yahoo! Finance]